230 Startups Using Artificial Intelligence in Drug Discovery

"Uses AI to: Simulate and generate digital control subjects that are statistically indistinguishable from actual controls. Allows researchers to: Populate control arms in clinical trials, enabling rigorous clinical evidence with fewer subjects. Founded: 2017. Headquarters: San Francisco, California, United States."

Enter your email address to download paper.

Click the link to begin download.
Oops! Something went wrong while submitting the form.
Blog

CTAD 2020: Unlearn will present abstracts to demonstrate how Digital Twins enable smaller, more efficient trials

Blog

Announcing The Unlearn Opportunities Internship Program

Podcasts

UCSF Rosenman Institute - The Health Technology Podcast #59: Digital Twins for Clinical Trials

Charles Fisher: Digital Twins for Clinical Trials
Creating Opportunities for Students of Data Science and Business from Underrepresented Groups in STEM
Unlearn will present data from two separate abstracts demonstrating how Digital Twins can power novel trial designs and accelerate timelines.